The term refers to a specific chemical compound, N-(pyridine-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, which is an intermediate used in the synthesis of the cancer medication acalabrutinib CAS No: - 1383385-64-5
| • Molecular Formula | C18H21BN2O3cap C sub 18 cap H sub 21 cap B cap N sub 2 cap O sub 3 |
| • Molecular Weight | 324.19 g/mol |
| • Appearance: | White to off-white solid |
| • Purity: | Typically listed as ≥97%is greater than or equal to 97 % |
| Packing :- | Powder form :- 25 Kg in HEDP bag with 2 liners (5 layer protected bag) |